Modeling the 3q26 OncCassette using genetically engineered mice

被引：0
|
作者：
Meneses, Kayleah M.
Liu, Yi
Weems, Capella R.
Jamieson, Lee
Nguyen, Duy T.
Justilien, Verline
Murray, Nicole R.
Fields, Alan P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1434
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features
    Testoni, N
    Borsaru, G
    Martinelli, G
    Carboni, C
    Ruggeri, D
    Ottaviani, E
    Pelliconi, S
    Ricci, P
    Pastano, R
    Visani, G
    Zaccaria, A
    Tura, S
    HAEMATOLOGICA, 1999, 84 (08) : 690 - 694
  • [22] Ryanodine receptor studies using genetically engineered mice
    Kushnir, Alexander
    Betzenhauser, Matthew J.
    Marks, Andrew R.
    FEBS LETTERS, 2010, 584 (10): : 1956 - 1965
  • [23] Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
    S Andersson
    K-L Wallin
    A-C Hellström
    L E Morrison
    A Hjerpe
    G Auer
    T Ried
    C Larsson
    K Heselmeyer-Haddad
    British Journal of Cancer, 2006, 95 : 331 - 338
  • [24] T(2/3)(P13/Q26) IN A CASE OF CHRONIC MYELOID-LEUKEMIA - IMPORTANCE OF THE INVOLVEMENT OF 3Q26
    KWONG, YL
    CHAN, LC
    LIE, KW
    CANCER GENETICS AND CYTOGENETICS, 1992, 59 (01) : 95 - 96
  • [25] Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
    Andersson, S.
    Wallin, K-L
    Hellstroem, A-C
    Morrison, L. E.
    Hjerpe, A.
    Auer, G.
    Ried, T.
    Larsson, C.
    Heselmeyer-Haddad, K.
    BRITISH JOURNAL OF CANCER, 2006, 95 (03) : 331 - 338
  • [26] 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: Biological and clinical features.
    Testoni, N
    Martinelli, G
    Carboni, C
    Pelliconi, S
    Ruggeri, D
    Ottaviani, E
    Ricci, P
    Borsaru, G
    Pastano, R
    Visani, G
    Zaccaria, A
    Tura, S
    BLOOD, 1998, 92 (10) : 76A - 76A
  • [27] 3q26 Gene Amplification in a Woman With Abnormal Cervical Cytology Unconfirmed by Cervical Biopsies
    Romano, Patricia
    Ottenheimer, Deborah
    Kilpatrick, Michael W.
    Tsipouras, Petros
    Walat, Robert J.
    LABMEDICINE, 2013, 44 (03): : 267 - 270
  • [28] 3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study
    Heitmann, Erica R.
    Lankachandra, Kamani M.
    Wall, Jeff
    Harris, George D.
    McKinney, Hollie J.
    Jalali, G. Reza
    Verma, Yogita
    Kershnar, Eric
    Kilpatrick, Michael W.
    Tsipouras, Petros
    Harper, Diane M.
    PLOS ONE, 2012, 7 (07):
  • [29] Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers
    Hagerstrand, Daniel
    Tong, Alexander
    Schumacher, Steven E.
    Ilic, Nina
    Shen, Rhine R.
    Cheung, Hiu Wing
    Vazquez, Francisca
    Shrestha, Yashaswi
    Kim, So Young
    Giacomelli, Andrew O.
    Rosenbluh, Joseph
    Schinzel, Anna C.
    Spardy, Nicole A.
    Barbie, David A.
    Mermel, Craig H.
    Weir, Barbara A.
    Garraway, Levi A.
    Tamayo, Pablo
    Mesirov, Jill P.
    Beroukhim, Rameen
    Hahn, William C.
    CANCER DISCOVERY, 2013, 3 (09) : 1044 - 1057
  • [30] GAIN OF 3Q26 AS A PROGNOSTIC BIOMARKER FOR HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
    Koeneman, M. M.
    Ovestad, I. T.
    Janssen, E. A. M.
    Ummelen, M.
    Kruitwagen, R. F. P. M.
    Hopman, A. H.
    Kruse, A. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 795 - 796
12345